{
    "Trade/Device Name(s)": [
        "OPTIGEN Allergen-Specific IgE Assay System",
        "OPTIGEN Positive Allergy Control Reagent",
        "OPTIGEN Negative Allergy Control Reagent"
    ],
    "Submitter Information": "Hitachi Chemical Diagnostics",
    "510(k) Number": "K051677",
    "Predicate Device Reference 510(k) Number(s)": [
        "K030590",
        "K962274"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB",
        "DGC"
    ],
    "Summary Letter Date": "June 21, 2005",
    "Summary Letter Received Date": "June 29, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5750",
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) Immunological Test System"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "IgE antibodies specific to 20 allergens"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Solid phase assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Hitachi OPTIGEN Allergen-Specific IgE Assay System for semi-quantitative measurement of allergen-specific IgE in human serum",
    "Indications for Use Summary": "In vitro test to semi quantitatively measure circulating allergen-specific IgE antibodies in human serum to assist in the clinical diagnosis of IgE-mediated allergic disorders for use in clinical laboratories",
    "fda_folder": "Immunology"
}